Cataract surgery has changed greatly over the past several decades. At SoCal Eye, we bring the latest cataract surgery technology and techniques together under one roof. Our patients have outstanding results following their procedures, and we know you will too!

SoCal Eye is also now offering patients the iStent, a microscopic stent that can be placed during cataract surgery to help treat glaucoma.

Technology has always played an important role in eye care. Today, almost every aspect of vision is connected to a product or procedure that wasn’t available even ten short years ago.Cataract surgery is a good example of how innovations can make a difference. Every aspect of it utilizes recently developed technology that will help us improve your vision. Today, this includes managing your mild-to-moderate open-angle glaucoma: because now we are able to add another step to your cataract surgery that allows you to treat your open-angle glaucoma in a completely new way. This is important because once diagnosed, you and most patients like you will spend the rest of your lives putting one, two or even three different kinds of drops in every day. Unfortunately, all of these drops will not only be inconvenient, but potentially very expensive. The iStent Trabecular Micro-Bypass Stent is designed to reduce your eye pressure and you can have it done at the same time you have cataract surgery.

iStent works like the stents used to prevent heart attacks and strokes. When blood vessels get
clogged, a stent creates access to the vessel flow. While a highly innovative technology, how
iStent works is elegantly simple:

  • If you have glaucoma, over time the eye’s natural drainage system becomes clogged
  • iStent creates a permanent opening through the blockage to improve the eye’s
    natural outflow
  • Restoring this mechanism lowers and controls pressure within the eye

iStent is implanted during your cataract surgery procedure. Once implanted, iStent will begin
working to safely and effectively manage pressure. What’s more, patients who receive iStent
may experience a reduction in glaucoma medications; but this will be at the discretion of your
physician.

For more information on the iStent ask our physicians during your cataract and glaucoma appointment.

Courtesy of the Glaukos Corporation. ©2012 Glaukos Corporation. iStent and Glaukos are registered trademarks of Glaukos Corporation. 400-0041-2012-US Rev. 1